Skip to main content
Public Health Nutrition logoLink to Public Health Nutrition
. 2013 Oct 10;17(8):1825–1833. doi: 10.1017/S1368980013002565

A population-based dietary inflammatory index predicts levels of C-reactive protein in the Seasonal Variation of Blood Cholesterol Study (SEASONS)

Nitin Shivappa 1,2, Susan E Steck 1,2, Thomas G Hurley 1, James R Hussey 2, Yunsheng Ma 3, Ira S Ockene 4, Fred Tabung 1,2, James R Hébert 1,2,*
PMCID: PMC3983179  NIHMSID: NIHMS537028  PMID: 24107546

Abstract

Objective

To perform construct validation of the population-based Dietary Inflammatory Index (DII) using dietary data from two different dietary assessments and serum high-sensitivity C-reactive protein (hs-CRP) as the construct validator.

Design

Using data derived from (i) three 24 h dietary recalls (24HR) at baseline and at the end of each subsequent quarter (i.e. up to fifteen over a year) and (ii) a 7 d dietary recall (7DDR) measured at baseline and then quarterly, regression analyses were conducted to test the effect of the DII score on serum hs-CRP as dichotomous (≤3 mg/l, >3 mg/l), while controlling for important potential confounders.

Setting

Existing data from the Seasonal Variation of Blood Cholesterol Study (SEASONS), a longitudinal observational study of healthy participants recruited in Worcester, MA, USA and participants were followed for 1 year.

Subjects

Participants who had at least one hs-CRP measurement over her/his 1-year participation (n 495 for 24HR, n 559 for 7DDR).

Results

Higher DII scores were associated with values of hs-CRP >3 mg/l (OR = 1·08; 95 % CI 1·01, 1·16, P = 0·035 for the 24HR; and OR = 1·10; 95 % CI 1·02, 1·19, P = 0·015 for the 7DDR).

Conclusions

The population-based DII was associated with interval changes in hs-CRP using both the 24HR and 7DDR. The success of this first-of-a-kind attempt at relating individuals’ intakes of inflammation-modulating foods using this refined DII, and the finding that there is virtually no drop-off in predictive capability using a structured questionnaire in comparison to the 24HR standard, sets the stage for use of the DII in a wide variety of other epidemiological and clinical studies.

Keywords: Diet, Inflammation, C-reactive protein, Adults, Predictive ability


Inflammation is a response due to repeated ‘injury’, e.g. from cigarette smoking, infection or hypertension, and evidence is accumulating on the role of chronic inflammation in cancer( 1 ), with colon cancer being the most well described( 2 ). The inflammatory microenvironment includes production of cytokines and chemokines that also promote tumour initiation, growth and invasion( 3 ).

The acute-phase protein C-reactive protein (CRP) is produced in response to stimulation by interleukins, such as IL-6( 4 ). Although used as a marker of inflammation in such conditions as rheumatoid arthritis for many decades, the more recent development of a high-sensitivity C-reactive protein (hs-CRP) assay permitted the detection of inflammation at the vascular level( 5 ). Many studies have shown that CRP is associated with a number of CVD end points( 6 ). In addition, CRP and inflammatory cytokines such as IL-6 and TNF-α are increased among obese individuals, positively correlated with BMI, and central adiposity has been shown to be associated with increased inflammation( 7 ). Higher levels of IL-6 among obese individuals are associated with insulin resistance( 8 ). Ridker et al.( 9 ) found that each component of the metabolic syndrome (obesity, hypertriacylglycerolaemia, low HDL-cholesterol, hypertension, abnormal glucose metabolism) is significantly associated with higher levels of hs-CRP.

Diet is known to play a major and significant role in the regulation of chronic inflammation. Previous research has shown an inverse association between fruit and vegetable consumption and inflammatory markers such as CRP, IL-6 and TNF-α( 10 ). The ‘Western’ diet, which is high in red meat, high-fat dairy products, refined grains and simple carbohydrates, has been associated with higher levels of CRP and IL-6( 11 ). On the other hand, the Mediterranean diet, which is high in whole grains, fish, fruit and green vegetables, with moderate alcohol and olive oil intakes, and low in red meat and butter, has been associated with lower levels of inflammation( 12 16 ). Diets high in fruits and vegetables have been associated with lower levels of CRP( 17 19 ). Specific nutrients such as n-3 PUFA( 20 25 ), fibre( 26 30 ), moderate alcohol intake( 31 33 ), vitamin E( 25 , 34 40 ), vitamin C( 34 , 41 43 ), β-carotene( 25 , 34 , 44 46 ) and magnesium( 26 , 47 49 ) also have consistently been shown to be associated with lower levels of inflammation.

Over the past three years, we have developed a Dietary Inflammatory Index (DII) that can be used in different data sets across diverse population in order to predict levels of inflammatory markers and related health outcomes( 50 ). We have substantially modified the DII since the original publication in 2009( 51 ). As described in a companion article( 50 ), this moves beyond typical dietary indices in the rigour applied to reviewing the literature (nearly 2000 articles were read and scored) and ‘anchoring’ this to what people actually eat (the final DII is based on actual food consumption data from eleven populations around the world). In this paper, we describe results of fitting this DII to two different sources of dietary intake information in order to predict hs-CRP in a longitudinal study of diet and inflammation.

Materials and methods

Study design

Briefly, the Seasonal Variation of Blood Cholesterol Study (SEASONS) was a prospective observational study. A total of 641 healthy participants were followed for 1 year, with data obtained at baseline and then every 3 months, within a 3-week window on either side of the individual's quarterly appointment date, to the 1-year anniversary point (total of five assessments). Eligibility criteria included being a resident of Worcester County (MA, USA), age 20–70 years and having telephone service. Study participants were not taking cholesterol-lowering medications (e.g. statins) and were not actively on lipid-lowering or weight-control diets, did not have possible causes of secondary hyperlipidaemia, had not been diagnosed as having CHD, and were free of life-threatening illness. Individuals were recruited between December 1994 and February 1997 and enrolment occurred throughout the calendar year. The Institutional Review Boards of the Fallon Healthcare System and the University of Massachusetts Medical School approved all subject recruitment and data collection procedures. Each individual signed an approved informed consent form before entering the study.

The SEASONS data set was selected for testing the DII for two reasons: (i) it had extremely high-quality data on individual-level exposure to food parameters; and (ii) it had hs-CRP data corresponding to each dietary measure. Details of the SEASONS are provided elsewhere( 52 , 53 ).

Eligible participants were scheduled for an in-clinic appointment. At the first visit, previously completed questionnaires were obtained, anthropometric measurements were taken and a fasting blood sample was drawn. Follow-up appointments were scheduled every 3 months for 1 year, for a total of five appointments. There was a 6-week window on both sides of each participant's quarterly appointment during which blood samples were obtained. Considerable information was collected on each participant. Questionnaire-derived data included: demographics, psychosocial measures, social desirability and approval measures, seasonal patterns in mood and behaviour, dietary information in the form of validated 7 d dietary recalls (7DDR)( 54 ) and 24 h recalls (24HR), and stress measures. Anthropometric measurements included height, weight, waist circumference and hip circumference. Blood pressure also was measured, as were serum hs-CRP and lipids.

Diet and physical activity assessment

Diet and physical activity were measured using the 24HR method. A set of three 24HR was administered on randomly selected days representing two weekdays and one weekend day at baseline and at each subsequent quarter. All dietary 24HR data were entered and analysed using the Nutrition Data System software (NDS V2·3). Values from the three dietary 24HR were averaged and these were used to calculate DII, thereby resulting in a single DII score for each individual at baseline and in each quarter. Participants also provided dietary data using the 7DDR. This structured instrument, consisting of questions on the amount (i.e. size and frequency) of consumption of 118 food and thirteen beverage items, was developed by Hebert et al.( 54 ) for use in the Worcester Area Trial for Counseling in Hyperlipidemia (WATCH) study, which was conducted in Greater Worcester, the same region in central Massachusetts in which SEASONS participants were recruited( 55 , 56 ). While the focus was primarily on parameters that would affect blood lipids, the validation of the instrument indicated that it provides long-term estimates of diet across a wide variety of nutrients( 54 ). The 7DDR is an optically scannable form that is filled out in less than 25 min. The form along with appropriate instructions was mailed to individuals prior to each of the five visits. For the 24HR, we were able to obtain intake values for forty-four of the forty-five food parameters required for DII calculation with the exception of trans-fat, because the version of NDS that was used did not calculate intake of trans-fat. However, owing to limited representation of dietary information on any structured questionnaire, data were available on twenty-eight of the forty-five food parameters for the 7DDR( 54 ). Physical activity was measured as part of the 24HR interview process using a previously validated method( 57 ), and output as energy expenditure overall and by domain as total metabolic equivalents of task (MET).

Serum collection and laboratory measurements

Blood was drawn at baseline and quarterly for up to 1 year (a total of five assessment periods). There was a 6-week window around the quarterly appointment to obtain serum samples from participants. This window spanned from 3 weeks before to 3 weeks after the scheduled appointment. Serum hs-CRP was analysed in the laboratory of Dr Nader Rifai at the Children's Hospital, Harvard Medical School, Boston, MA. The methodology was described previously( 58 ). Inter-assay and intra-assay CV for hs-CRP were in compliance with the ranges accepted by the US Centers for Disease Control and Prevention (CDC). Assays for total cholesterol, HDL-cholesterol and TAG were conducted in a CDC Standardized Laboratory( 53 ). LDL-cholesterol was calculated by the Friedewald formula( 59 ). When TAG exceeded 400 mg/dl, LDL-cholesterol was not calculated. Healthy male and female participants who had at least one hs-CRP measurement over her/his entire 1-year participation were included in the analysis.

Statistical analyses

Summary statistics were used to describe the study population at baseline separately for both 24HR and 7DDR subsets (as the numbers of participants with complete data from each were unequal; n 495 and n 559, respectively). Comparisons of baseline characteristics by sex were made using χ 2 tests for categorical variables and two-sample t tests for continuous variables. DII was converted to tertiles and tests for trend across DII tertiles were carried out for age, smoking status, hs-CRP, BMI, MET/d, LDL-cholesterol and HDL-cholesterol. Generalized linear mixed models (proc GLIMMIX in SAS) were used for more complex analyses. Here, we used a compound symmetry covariance matrix to account for the dependence of observations made on the same individuals. The primary outcome variable for this analysis was hs-CRP, which was dichotomized to ≤3 mg/l and >3 mg/l, and the odds of elevated hs-CRP (>3 mg/l) was determined. Values of hs-CRP >10 mg/l were excluded from the total number of observations because this may be a result of acute inflammation; only sixty-five such values (3 % of the total) were excluded from the total of 2165 available hs-CRP measures as a consequence of this( 60 ). The primary independent variable was the score obtained from the DII and tertiles of DII. Both unadjusted and adjusted analyses were carried out. We also tested for effect modification between DII score and categories of BMI, age and infection status by including interaction terms in the model. Variables controlled in analyses were age, sex, race, BMI, smoking status, alcohol consumption status, physical activity, marital status, HDL-cholesterol, total cholesterol, anti-inflammatory medication use, light season, herbal supplement use, and a variable indicating if the participant had an infection during the study quarter. Race was dichotomized into ‘White’ and ‘Other’ because 90 % of the study population was White. BMI was categorized into normal weight (18·5 to <25·0 kg/m2), overweight (25·0 to <30·0 kg/m2) and obese (≥30·0 kg/m2). Participants considered underweight (<18·5 kg/m2) were excluded from analysis. Smoking status was dichotomized as yes/no. Level of education was categorized into high-school graduate or less, vocational/trade and some college, and college graduate or more. Marital status was categorized into single, married, living with a partner, separated, divorced or widowed. Total cholesterol and HDL-cholesterol were left as continuous variables. Seasons were categorized using the ‘light season’ definition centred at the equinoxes/solstices (winter: 6 November to 4 February; spring: 5 February to 6 May; summer: 7 May to 5 August; and autumn: 6 August to 5 November). Participants who reported having arthritis were excluded from analysis. Also, observations missing hs-CRP were excluded from analysis. All data analyses were performed using the SAS® statistical software package version 9·2.

Results

A total of 519 participants for 24HR and 586 for 7DDR had at least one clinic visit with hs-CRP data available. After excluding participants with hs-CRP >10 mg/l, arthritis, BMI <18·5 kg/m2 and those missing any of the measurements for the covariates entered in the model, the final sample size for the analysis was 495 for the 24HR and 559 for the 7DDR with baseline data. The number of follow-up quarterly measurements available for the 24HR totalled 1672 (an average of ≈3·4 per participant), and for the 7DDR 1839 (an average of ≈3·3 per participant). Most participants (nearly 75 %) had both an hs-CRP measurement and at least one 24HR at three or more measurement points: 12 % had such paired data at one point, 14 % at two points, 20 % at three, 26 % at four and 28 % had paired data at all five points. For hs-CRP and 7DDR, the percentages with both were similar: 14 % with both at one point, 16 % with two, 20 % with three, 26 % with four and 24 % with both at all five points.

Baseline characteristics of the participants are presented by sex (Table 1). The majority of the participants were White, married and working full time. The mean age was 49 (sd 12) years. Compared with females, males were more likely to be overweight, married, working full time and to have a higher level of education.

Table 1.

Baseline characteristics of the participants (categorical variables); Dietary Inflammatory Index Development and Testing Study, Columbia, SC, USA, 2011–2012

24HR-derived data 7DDR-derived data
Males (n 264) Females (n 231) Males (n 292) Females (n 267)
Characteristic* n % n % P value† n % n % P value†
Race 0·72 0·13
White (Non-Hispanic) 236 89·7 205 88·8 258 89·0 225 84·6
Other 28 10·3 26 11·3 32 11·0 41 15·4
Current smoker 0·27 0·45
Yes 49 18·6 37 16·0 53 18·1 42 15·7
No 215 81·4 194 84·0 239 81·9 225 84·3
BMI (kg/m2) 0·01 0·0005
Normal weight (>18·5 to <25·0) 82 31·1 102 44·2 85 29·1 120 44·9
Overweight (25·0 to <30·0) 114 43·2 80 34·6 128 44·1 91 34·1
Obese (≥30·0) 68 25·8 49 21·2 78 26·7 56 21·0
Marital status 0·003 0·003
Single 26 9·9 22 9·5 29 10·0 30 11·2
Married/living together 217 82·1 169 73·2 239 82·1 195 72·7
Separated/divorced/widowed 21 8·0 40 17·3 24 7·9 43 16·1
Employment status 0·0004 0·0002
Full time 196 74·2 134 58·0 219 75·0 157 58·8
Part time 29 11·0 49 21·2 31 10·6 54 20·2
Unemployed 39 14·8 48 20·8 42 14·4 56 21·0
Job type <0·0001 <0·0001
Skill or craft 28 12·6 14 8·1 31 12·6 13 6·5
Machine operator 6 2·7 0 0·0 9 3·6 1 0·5
Manual labour 15 6·8 8 4·6 20 8·1 12 6·0
Scientific technical work 25 11·3 8 4·6 29 11·7 9 4·5
Service work 20 9·0 20 11·6 23 9·3 23 11·6
Clinical, office or sales professional 16 7·2 41 23·7 18 7·1 48 24·1
Managerial or administrative work 112 50·5 82 47·4 117 47·4 93 46·7
Education <0·0001 <0·0001
High school or less 47 17·6 84 36·5 48 16·4 90 33·7
Vocational/trade or some college 69 26·2 47 20·4 83 28·5 61 22·9
College or more 148 56·3 99 43·0 161 55·1 116 43·4
Vitamin/mineral supplements 0·005 0·0014
Yes 63 23·9 82 35·5 69 23·6 92 34·5
No 201 76·1 149 64·5 223 76·4 175 65·5
Alcohol consumption <0·0001 <0·0001
Yes 81 30·6 26 10·1 84 28·4 29 9·6
No 180 69·4 208 89·9 207 71·6 240 90·4
Anti-inflammatory medications 0·46 0·30
Yes 38 14·4 28 12·1 40 13·7 29 10·9
No 226 85·6 203 87·9 252 86·3 238 89·1

24HR, 24 h diet recall interviews; 7DDR, 7 d diet recall.

*Some of the categories do not sum to the total because of missing data.

P value for the χ 2 test of the hypothesis that there is no difference between genders.

Energy intake was higher among males than females (difference of 2812 kJ/d (672 kcal/d) for 24HR and 1456 kJ/d (348 kcal/d) for 7DDR; Table 2). For most nutrients, males had a significantly higher intake compared with females, largely because of their higher energy intake. Females had a significantly higher intake of vitamin or mineral supplements (Table 1). No difference was found in herbal supplement use and very few participants consumed fish-oil supplements (three participants in total). Approximately 13·5 % of the study population was using anti-inflammatory drugs at baseline in the 24HR subset compared with 12·5 % of those in the 7DDR subset (this was controlled for during analysis). Across all time points, the DII score ranged from 5·8 to −5·4 for the 24HR subset and from 4·3 to −5·3 for the 7DDR subset, which represents about 67 % and 57 %, respectively, of the range observed in the eleven-country data set used as our standard referent( 50 ). Mean DII score for the 24HR subset was 0·18 (sd 2·18) and the mean DII score for the 7DDR subset was 0·84 (sd 2·0).

Table 2.

Baseline characteristics of the participants (continuous variables); Dietary Inflammatory Index Development and Testing Study, Columbia, SC, USA, 2011–2012

24HR-derived data 7DDR-derived data
Males (n 264) Females (n 231) Males (n 292) Females (n 267)
Characteristic Mean sd Mean sd P value* Mean sd Mean sd P value*
DII 0·11 1·98 0·75 2·14 0·01 0·52 2·0 0·95 1·9 0·01
Age (years) 49·3 12·3 48·4 11·7 0·43 48·5 12·5 47·3 12·0 0·24
Serum hs-CRP (mg/l) 2·4 4·6 2·2 5·7 0·73 2·3 4·4 2·2 5·1 0·75
Total physical activity (MET-h/d) 32·0 7·4 29·1 3·9 <0·0001 32·1 7·7 28·9 03·9 <0·0001
Energy intake (kJ/d) 9464 3335 6653 1531 <0·0001 9042 3623 7586 4075 <0·0001
Energy intake (kcal/d) 2262 797 1590 366 <0·0001 2161 866 1813 974 <0·0001
HDL-C (mg/dl) 43·4 11·3 51·3 12·3 <0·0001 43·2 11·0 51·7 12·9 <0·0001
SBP (mmHg) 126·8 18·1 113·7 18 <0·0001 126·7 18·0 113·3 17·2 <0·0001

24HR, 24 h diet recall interviews; 7DDR, 7 d diet recall; DII, Dietary Inflammatory Index; hs-CRP, high-sensitivity C-reactive protein; MET, metabolic equivalents of task (a physiological measure expressing the energy cost of physical activities); HDL-C, HDL-cholesterol; SBP, systolic blood pressure.

*P value for the two-sample t test of the hypothesis that there is no difference between genders.

As presented in Table 3, tests for trends across DII tertiles revealed significant increasing trends for hs-CRP (P < 0·0001 in both 24HR and 7DDR subsets), BMI (P < 0·0001 in the 24HR subset and P = 0·002 in the 7DDR subset) and serum LDL-cholesterol (P = 0·009 for 24HR and P < 0·0001 for 7DDR) while a significant decreasing trend was observed for total physical activity (MET-h/d) in the 24HR subset (P < 0·0001).

Table 3.

Characteristics of the participants according to DDI tertile; Dietary Inflammatory Index Development and Testing Study, Columbia, SC, USA, 2011–2012

DII for 24HR-derived data DII for 7DDR-derived data
Tertile 1 Tertile 2 Tertile 3 Tertile 1 Tertile 2 Tertile 3
(≤−0·66) (−0·65 to (+)1·45) (>1·46) (≤0·08) (0·081 to (+)1·94) (>1·94)
Characteristic Mean or n sd or % Mean or n sd or % Mean or n sd or % P value* Mean or n sd or % Mean or n sd or % Mean or n sd or % P value*
Age (years) 49·1 11·2 49·0 12·3 47·2 11·7 0·13 48·3 12·0 48·8 12·0 49·0 12·1 0·30
Current smoker (%) 0·14 0·10
Yes 48 16·3 16 16·2 22 21·6 31 15·1 28 16·0 36 20·1
No 246 83·7 83 83·8 80 78·4 174 84·9 147 84·0 143 79·9
Serum hs-CRP (mg/l) 1·5 1·6 1·7 1·9 2·0 2·0 <0·0001 1·4 1·5 1·8 2·1 1·9 1·9 <0·0001
MET/d 31·0 5·7 30·0 6·2 29·3 5·0 <0·0001 30·6 6·0 29·6 5·0 30·2 6·0 0·19
BMI (kg/m2) 26·5 4·5 27·2 5·0 28·1 5·9 <0·0001 26·7 5·0 27·2 4·9 27·6 5·5 0·002
LDL-C (mg/dl) 140·4 34·2 145·0 35·3 146·1 37·4 0·009 136·7 34·6 143·5 36·5 152·9 38·3 <0·0001
HDL-C (mg/dl) 46·3 11·8 48·0 12·8 47·7 12·3 0·06 47·8 12·6 47·6 12·2 47·4 12·2 0·64

DII, Dietary Inflammatory Index; 24HR, 24 h diet recall interviews; 7DDR, 7 d diet recall; hs-CRP, high-sensitivity C-reactive protein; MET, metabolic equivalents of task (a physiological measure expressing the energy cost of physical activities); LDL-C, LDL-cholesterol; HDL-C, HDL-cholesterol.

Data are presented as mean and standard deviation except for current smoker, which is presented as number and percentage.

*P value for trend across tertiles of DII.

Analysis of high-sensitivity C-reactive protein as dichotomous

As recommended by the CDC and the American Heart Association, we dichotomized hs-CRP at the level of 3 mg/l, considering measurements greater than this level at higher CVD risk( 60 ). A total of 302 observations (18 % of the total 1672 observations) for 24HR and 323 observations (18 % of the total of 1839 observations) for 7DDR had an elevated hs-CRP; i.e. >3 mg/l. Unadjusted analysis with continuous DII as the independent variable yielded significant results in both the 24HR and 7DDR subsets (OR = 1·06; 95 % CI 1·00, 1·12 for 24HR and OR = 1·10; 95 % CI 1·03, 1·17 for 7DDR). Results from adjusted analysis revealed a significant association between DII score and elevated hs-CRP; a 1-point increase in score was associated with an increased odds of elevated hs-CRP for both subgroups (OR = 1·08; 95 % CI 1·01, 1·16 for 24HR and OR = 1·10; 95 % CI 1·02, 1·19 for 7DDR; Table 4). Analysis with DII as tertiles revealed significant associations between DII in tertiles 3 and 2, compared with tertile 1 (tertile 3 v. 1, OR = 1·47; 95 % CI 1·03, 2·12; tertile 2 v. 1, OR = 1·35; 95 % CI 1·01, 1·81) for the 24HR subset, whereas for the 7DDR subset a significant association was seen between tertile 3 and tertile 1 (OR = 1·61; 95 % CI 1·15, 2·27). In addition, age, HDL-cholesterol and absence of an infection during the study quarter were significantly associated with hs-CRP in both subsets. Overweight and obese individuals had significantly higher odds of an elevated hs-CRP compared with normal-weight individuals. No other variable entered into the model was significantly associated with hs-CRP. We examined the association between DII score and the dichotomous hs-CRP with stratification by infection status. The effect of the DII score was not different among those with v. without an infection; therefore, we reported only the overall odds ratios here. A 5-point increase in the 24HR-derived DII score was associated with ≈50 % increase in the odds of an elevated hs-CRP (OR = 1·47; 95 % CI 1·03, 2·10), while a 10-point increase more than doubled the odds (OR = 2·15; 95 % CI 1·06, 4·40). Similarly, a 5-point increase in the 7DDR-derived score was associated with a 60 % increase in the odds of an elevated hs-CRP (OR = 1·60; 95 % CI 1·09, 2·36), while a 10-point increase more than doubled the odds ratio (OR = 2·56; 95 % CI 1·18, 5·56). This new population-based DII was more highly correlated with hs-CRP (r = 0·11, P < 0·0001) than was the old DII (r = 0·04, P = 0·08).

Table 4.

Summary of logistic regression analysis based on hs-CRP as a dichotomous variable (≤3 mg/l, >3 mg/l); Dietary Inflammatory Index Development and Testing Study, Columbia, SC, USA, 2011–2012

24HR-derived data 7DDR-derived data
Unadjusted Adjusted* Unadjusted Adjusted*
Variables OR 95 % CI OR 95 % CI OR 95 % CI OR 95 % CI
DII (continuous) 1·06 1·00, 1·12 1·08 1·01, 1·16 1·10 1·03, 1·17 1·10 1·02, 1·19
DII (tertiles)
Tertile 2 v. tertile 1 1·27 0·98, 1·64 1·35 1·01, 1·81 1·14 0·85, 1·49 1·02 0·76, 1·34
Tertile 3 v. tertile 1 1·32 0·98, 1·79 1·47 1·03, 2·12 1·96 1·43, 2·63 1·61 1·15, 2·27

hs-CRP, high-sensitivity C-reactive protein; 24HR, 24 h diet recall interviews; 7DDR, 7 d diet recall; DII, Dietary Inflammatory Index.

*Results (odds ratios and associated 95 % confidence intervals) shown are obtained from the logistic regression model, which controlled for all variables shown with additional control for MET (metabolic equivalents of task), gender, light season, race, marital status, serum total cholesterol, employment status, anti-inflammatory medication use, alcohol status and herbal supplement use.

Discussion

Updating the literature database and refinement of the scoring algorithms for the DII appeared to increase construct validation in SEASONS, a study ideally suited for this purpose because of carefully collected dietary exposure (i.e. multiple 24HR and 7DDR) and hs-CRP measures demarcating the four seasons of the year in adult female and male participants. We were able to predict hs-CRP levels ≤3 mg/l v. >3 mg/l using the DII applied to the dietary assessment methods in SEASONS.

Because an hs-CRP value of >3 mg/l is recommended as a relevant clinical cut-off point for identifying individuals at high CVD risk( 60 ), we were particularly interest in the association between the DII and hs-CRP as a dichotomous variable. Using multiple 24HR-derived data, we found that a pro-inflammatory diet, as defined by the DII, was associated with an increase in the odds of an elevated hs-CRP (>3 mg/l). We also were very interested in whether there would be a large drop-off in predictive ability in going from multiple 24HR, which are too expensive to be used in most epidemiological studies, to use of a structured questionnaire typical of larger-scale studies. Even though the total number of food parameters used to compute the DII for the 7DDR is less than that used for the DII applied to the 24HR (twenty-eight v. forty-four), there was uniform distribution of pro- and anti-inflammatory food parameters in the available data and, most importantly, virtually no degradation in predictive ability. In all models, we controlled for age( 61 ) and BMI( 62 , 63 ), which are known predictors of CRP.

Despite its racial homogeneity (consisting of ∼90 % non-Hispanic Whites), there are a number of strengths in using SEASONS. It is one of the few studies where both multiple-day 24HR and structured questionnaire were used to collect dietary data. The 24HR is the most accurate method for measuring macronutrient and micronutrient intakes, owing to its ability to assess intake of foods, such as spices, that are not commonly found on structured instruments but which may have a substantial effect on inflammation despite that they tend to be consumed in small quantities in the USA( 64 ). Like most such structured instruments, the 7DDR, with its focus on long-term intake of macronutrients especially dietary fat, did not measure such foods. Still, its predictive ability seems unimpaired; perhaps owing to the infrequency of consuming these foods in this population.

Another strength of the SEASONS is that the sample size is large for both data subsets, thus providing a robust estimate of the association between the DII and hs-CRP. Within SEASONS, there also is a wealth of information collected at each time point. This allowed appropriate control for a number of other variables, which in turn decreased the possibility of uncontrolled confounding as an explanation for our results.

It is important to note that SEASONS is an observational study; therefore, it is remarkable to observe significant prediction of interval changes in hs-CRP by the DII in the absence of an intervention. Despite that it focuses mainly on White Americans, the values obtained from the 24HR and the 7DDR in SEASONS represent a wide range of the global range of the DII (i.e. 67 % and 57 %, respectively)( 50 ).

In summary, we found that the DII was able to predict odds of having an elevated hs-CRP in SEASONS, a longitudinal study with high-quality dietary and inflammation-related data obtained at baseline and at the end of each of four seasons over a year, using both the 24HR- and 7DDR-derived dietary data.

Acknowledgements

Sources of funding: This work was supported by the South Carolina Statewide Cancer Prevention and Control Program Research Fund and the National Heart, Lung, and Blood Institute (grant #1R01 HL073194, SEASONS Study; Principal Investigator I.S.O.). J.R. Hébert was supported by an Established Investigator Award in Cancer Prevention and Control from the Cancer Training Branch of the National Cancer Institute (K05 CA136975). Y.M. was supported by grant #1R01HL094575-01A1 from the National Heart, Lung, and Blood Institute. The National Heart, Lung, and Blood Institute and the National Cancer Institute had no role in the design, analysis or writing of this article. Conflicts of interest: None of the authors declares a conflict of interest. The SEASONS was approved by the University of Massachusetts Institutional Review Board but for the purpose of the current analysis the Institutional Review Board approval was exempt. Authors’ contributions: N.S. was involved in the design of the DII, analysed data from SEASONS and collaborated with J.R. Hébert in writing the original draft of the paper; S.E.S. was involved in design of the DII and provided critical input in revising drafts of the paper; T.G.H. was involved in the design of the DII, provided statistical expertise and helped to write the paper; J.R. Hussey was involved in analysing the data, provided high-level statistical expertise and input in writing the paper; Y.M. provided consultation on analysing the SEASONS data and participated in writing the paper; I.S.O. provided high-level consultation on the SEASONS and input in writing the paper; F.T. provided consultation to N.S. in fitting the models and input in writing the paper; J.R. Hébert devised the initial DII concept, guided all phases of the design of the DII, supervised the analysis of the data used in validating the DII and took the lead in writing the paper.

References

  • 1. Keibel A, Singh V & Sharma MC (2009) Inflammation, microenvironment, and the immune system in cancer progression. Curr Pharm Des 15, 1949–1955. [DOI] [PubMed] [Google Scholar]
  • 2. Terzic J, Grivennikov S, Karin E et al. (2010) Inflammation and colon cancer. Gastroenterology 138, 2101–2114.e5. [DOI] [PubMed] [Google Scholar]
  • 3. Jackson L & Evers BM (2006) Chronic inflammation and pathogenesis of GI and pancreatic cancers. Cancer Treat Res 130, 39–65. [DOI] [PubMed] [Google Scholar]
  • 4. Erlinger TP, Platz EA, Rifai N et al. (2004) C-reactive protein and the risk of incident colorectal cancer. JAMA 291, 585–590. [DOI] [PubMed] [Google Scholar]
  • 5. Ridker PM, Glynn RJ & Hennekens CH (1998) C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 97, 2007–2011. [DOI] [PubMed] [Google Scholar]
  • 6. Ridker PM, Rifai N, Rose L et al. (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347, 1557–1565. [DOI] [PubMed] [Google Scholar]
  • 7. Hermsdorff HH, Zulet MA, Puchau B et al. (2011) Central adiposity rather than total adiposity measurements are specifically involved in the inflammatory status from healthy young adults. Inflammation 34, 161–170. [DOI] [PubMed] [Google Scholar]
  • 8. Bastard JP, Jardel C, Bruckert E et al. (2000) Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 85, 3338–3342. [DOI] [PubMed] [Google Scholar]
  • 9. Ridker PM, Buring JE, Cook NR et al. (2003) C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107, 391–397. [DOI] [PubMed] [Google Scholar]
  • 10. Hermsdorff HH, Zulet MA, Puchau B et al. (2010) Fruit and vegetable consumption and proinflammatory gene expression from peripheral blood mononuclear cells in young adults: a translational study. Nutr Metab (Lond) 7, 42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Esmaillzadeh A, Kimiagar M, Mehrabi Y et al. (2007) Dietary patterns and markers of systemic inflammation among Iranian women. J Nutr 137, 992–998. [DOI] [PubMed] [Google Scholar]
  • 12. Dalziel K, Segal L & de Lorgeril M (2006) A Mediterranean diet is cost-effective in patients with previous myocardial infarction. J Nutr 136, 1879–1885. [DOI] [PubMed] [Google Scholar]
  • 13. Chrysohoou C, Panagiotakos DB, Pitsavos C et al. (2004) Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: the ATTICA Study. J Am Coll Cardiol 44, 152–158. [DOI] [PubMed] [Google Scholar]
  • 14. Esposito K, Marfella R, Ciotola M et al. (2004) Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 292, 1440–1446. [DOI] [PubMed] [Google Scholar]
  • 15. Estruch R, Martinez-Gonzalez MA, Corella D et al. (2006) Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med 145, 1–11. [DOI] [PubMed] [Google Scholar]
  • 16. Serrano-Martinez M, Palacios M, Martinez-Losa E et al. (2005) A Mediterranean dietary style influences TNF-α and VCAM-1 coronary blood levels in unstable angina patients. Eur J Nutr 44, 348–354. [DOI] [PubMed] [Google Scholar]
  • 17. Gao X, Bermudez OI & Tucker KL (2004) Plasma C-reactive protein and homocysteine concentrations are related to frequent fruit and vegetable intake in Hispanic and non-Hispanic white elders. J Nutr 134, 913–918. [DOI] [PubMed] [Google Scholar]
  • 18. Watzl B, Kulling SE, Moseneder J et al. (2005) A 4-wk intervention with high intake of carotenoid-rich vegetables and fruit reduces plasma C-reactive protein in healthy, nonsmoking men. Am J Clin Nutr 82, 1052–1058. [DOI] [PubMed] [Google Scholar]
  • 19. Esmaillzadeh A, Kimiagar M, Mehrabi Y et al. (2006) Fruit and vegetable intakes, C-reactive protein, and the metabolic syndrome. Am J Clin Nutr 84, 1489–1497. [DOI] [PubMed] [Google Scholar]
  • 20. Ferrucci L, Cherubini A, Bandinelli S et al. (2006) Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab 91, 439–446. [DOI] [PubMed] [Google Scholar]
  • 21. Lopez-Garcia E, Schulze MB, Manson JE et al. (2004) Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 134, 1806–1811. [DOI] [PubMed] [Google Scholar]
  • 22. Niu K, Hozawa A, Kuriyama S et al. (2006) Dietary long-chain n-3 fatty acids of marine origin and serum C-reactive protein concentrations are associated in a population with a diet rich in marine products. Am J Clin Nutr 84, 223–229. [DOI] [PubMed] [Google Scholar]
  • 23. Zampelas A, Panagiotakos DB, Pitsavos C et al. (2005) Fish consumption among healthy adults is associated with decreased levels of inflammatory markers related to cardiovascular disease: the ATTICA study. J Am Coll Cardiol 46, 120–124. [DOI] [PubMed] [Google Scholar]
  • 24. Zhao G, Etherton TD, Martin KR et al. (2004) Dietary α-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J Nutr 134, 2991–2997. [DOI] [PubMed] [Google Scholar]
  • 25. Gunter MJ, Stolzenberg-Solomon R, Cross AJ et al. (2006) A prospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Res 66, 2483–2487. [DOI] [PubMed] [Google Scholar]
  • 26. Bo S, Durazzo M, Guidi S et al. (2006) Dietary magnesium and fiber intakes and inflammatory and metabolic indicators in middle-aged subjects from a population-based cohort. Am J Clin Nutr 84, 1062–1069. [DOI] [PubMed] [Google Scholar]
  • 27. King DE, Egan BM & Geesey ME (2003) Relation of dietary fat and fiber to elevation of C-reactive protein. Am J Cardiol 92, 1335–1339. [DOI] [PubMed] [Google Scholar]
  • 28. Ajani UA, Ford ES & Mokdad AH (2004) Dietary fiber and C-reactive protein: findings from national health and nutrition examination survey data. J Nutr 134, 1181–1185. [DOI] [PubMed] [Google Scholar]
  • 29. King DE, Egan BM, Woolson RF et al. (2007) Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level. Arch Intern Med 167, 502–506. [DOI] [PubMed] [Google Scholar]
  • 30. Ma Y, Griffith JA, Chasan-Taber L et al. (2006) Association between dietary fiber and serum C-reactive protein. Am J Clin Nutr 83, 760–766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Avellone G, Di Garbo V, Campisi D et al. (2006) Effects of moderate Sicilian red wine consumption on inflammatory biomarkers of atherosclerosis. Eur J Clin Nutr 60, 41–47. [DOI] [PubMed] [Google Scholar]
  • 32. Sierksma A, van der Gaag MS, Kluft C et al. (2002) Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels; a randomized, diet-controlled intervention study. Eur J Clin Nutr 56, 1130–1136. [DOI] [PubMed] [Google Scholar]
  • 33. Imhof A, Froehlich M, Brenner H et al. (2001) Effect of alcohol consumption on systemic markers of inflammation. Lancet 357, 763–767. [DOI] [PubMed] [Google Scholar]
  • 34. van Herpen-Broekmans WM, Klopping-Ketelaars IA, Bots ML et al. (2004) Serum carotenoids and vitamins in relation to markers of endothelial function and inflammation. Eur J Epidemiol 19, 915–921. [DOI] [PubMed] [Google Scholar]
  • 35. Bertran N, Camps J, Fernandez-Ballart J et al. (2005) Diet and lifestyle are associated with serum C-reactive protein concentrations in a population-based study. J Lab Clin Med 145, 41–46. [DOI] [PubMed] [Google Scholar]
  • 36. Upritchard JE, Sutherland WH & Mann JI (2000) Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care 23, 733–738. [DOI] [PubMed] [Google Scholar]
  • 37. Devaraj S, Li D & Jialal I (1996) The effects of α tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1β secretion, and monocyte adhesion to endothelium. J Clin Invest 98, 756–763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. van Tits LJ, Demacker PN, de Graaf J et al. (2000) α-Tocopherol supplementation decreases production of superoxide and cytokines by leukocytes ex vivo in both normolipidemic and hypertriglyceridemic individuals. Am J Clin Nutr 71, 458–464. [DOI] [PubMed] [Google Scholar]
  • 39. Devaraj S & Jialal I (2000) α-Tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients. Free Radic Biol Med 29, 790–792. [DOI] [PubMed] [Google Scholar]
  • 40. Murphy RT, Foley JB, Tome MT et al. (2004) Vitamin E modulation of C-reactive protein in smokers with acute coronary syndromes. Free Radic Biol Med 36, 959–965. [DOI] [PubMed] [Google Scholar]
  • 41. Chien CT, Chang WT, Chen HW et al. (2004) Ascorbate supplement reduces oxidative stress in dyslipidemic patients undergoing apheresis. Arterioscler Thromb Vasc Biol 24, 1111–1117. [DOI] [PubMed] [Google Scholar]
  • 42. Korantzopoulos P, Kolettis TM, Kountouris E et al. (2005) Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation. Int J Cardiol 102, 321–326. [DOI] [PubMed] [Google Scholar]
  • 43. Wannamethee SG, Lowe GD, Rumley A et al. (2006) Associations of vitamin C status, fruit and vegetable intakes, and markers of inflammation and hemostasis. Am J Clin Nutr 83, 567–574. [DOI] [PubMed] [Google Scholar]
  • 44. Folsom AR, Desvarieux M, Nieto FJ et al. (2003) B vitamin status and inflammatory markers. Atherosclerosis 169, 169–174. [DOI] [PubMed] [Google Scholar]
  • 45. Erlinger TP, Guallar E, Miller ER 3rd et al. (2001) Relationship between systemic markers of inflammation and serum β-carotene levels. Arch Intern Med 161, 1903–1908. [DOI] [PubMed] [Google Scholar]
  • 46. Kritchevsky SB, Bush AJ, Pahor M et al. (2000) Serum carotenoids and markers of inflammation in nonsmokers. Am J Epidemiol 152, 1065–1071. [DOI] [PubMed] [Google Scholar]
  • 47. King DE, Mainous AG 3rd, Geesey ME et al. (2005) Dietary magnesium and C-reactive protein levels. J Am Coll Nutr 24, 166–171. [DOI] [PubMed] [Google Scholar]
  • 48. Song Y, Li TY, van Dam RM et al. (2007) Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women. Am J Clin Nutr 85, 1068–1074. [DOI] [PubMed] [Google Scholar]
  • 49. Song Y, Ridker PM, Manson JE et al. (2005) Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older US women. Diabetes Care 28, 1438–1444. [DOI] [PubMed] [Google Scholar]
  • 50. Shivappa N, Steck SE, Hurley TG et al. (2013) Designing and developing a literature-derived, population-based dietary inflammatory index. Public Health Nutr (Epublication ahead of print version). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Cavicchia PP, Steck SE, Hurley TG et al. (2009) A new dietary inflammatory index predicts interval changes in high-sensitivity C-reactive protein. J Nutr 139, 2365–2372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Merriam PA, Ockene IS, Hebert JR et al. (1999) Seasonal variation of blood cholesterol levels: study methodology. J Biol Rhythms 14, 330–339. [DOI] [PubMed] [Google Scholar]
  • 53. Ockene IS, Chiriboga DE, Stanek EJ 3rd et al. (2004) Seasonal variation in serum cholesterol levels: treatment implications and possible mechanisms. Arch Intern Med 164, 863–870. [DOI] [PubMed] [Google Scholar]
  • 54. Hebert JR, Ockene IS, Hurley TG et al. (1997) Development and testing of a seven-day dietary recall. J Clin Epidemiol 50, 925–937. [DOI] [PubMed] [Google Scholar]
  • 55. Hebert JR, Ebbeling CB, Ockene IS et al. (1999) A dietitian-delivered group nutrition program leads to reductions in dietary fat, serum cholesterol, and body weight: findings from the Worcester Area Trial for Counseling in Hyperlipidemia (WATCH). J Am Diet Assoc 99, 544–552. [DOI] [PubMed] [Google Scholar]
  • 56. Ockene IS, Hebert JR, Ockene JK et al. (1999) Effect of physician-delivered nutrition counseling training and an office support system on saturated fat intake, weight, and serum lipid measurements in a hyperlipidemic population: the Worcester-Area Trial for Counseling in Hyperlipidemia (WATCH). Arch Intern Med 159, 725–731. [DOI] [PubMed] [Google Scholar]
  • 57. Matthews CE, Hebert JR, Freedson P et al. (2000) Comparing physical activity assessment methods in the Seasonal Variation of Blood Cholesterol Study. Med Sci Sports Exer 32, 976–984. [DOI] [PubMed] [Google Scholar]
  • 58. Ockene IS, Matthews CE, Rifai N et al. (2001) Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem 47, 444–450. [PubMed] [Google Scholar]
  • 59. Friedewald WT, Levy RI & Frederickson DS (1972) Estimation of plasma low-density lipoprotein cholesterol concentration without use of the preparative ultracentrifuge. Clin Chem 18, 499–502. [PubMed] [Google Scholar]
  • 60. Pearson TA, Mensah GA, Alexander RW et al. (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107, 499–511. [DOI] [PubMed] [Google Scholar]
  • 61. Khor LL, Muhlestein JB, Carlquist JF et al. (2004) Sex- and age-related differences in the prognostic value of C-reactive protein in patients with angiographic coronary artery disease. Am J Med 117, 657–664. [DOI] [PubMed] [Google Scholar]
  • 62. Ma Y, Chiriboga DE, Pagoto SL et al. (2011) Association between depression and C-reactive protein. Cardiol Res Pract 2011, 286509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63. Wee CC, Mukamal KJ, Huang A et al. (2008) Obesity and C-reactive protein levels among white, black, and Hispanic US adults. Obesity (Silver Spring) 16, 875–880. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64. Hebert JR, Hurley TG, Chiraboga DE et al. (1998) A comparison of selected nutrient intakes derived from three diet assessment methods used in a low-fat maintenance trial. Public Health Nutr 1, 207–214. [DOI] [PubMed] [Google Scholar]

Articles from Public Health Nutrition are provided here courtesy of Cambridge University Press

RESOURCES